- Supported exchanges /
- NSE /
- LASA.NSE
Lasa Supergenerics Limited (LASA NSE) stock market data APIs
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Lasa Supergenerics Limited Financial Data Overview
| 24 | |
| 24.25 | |
| - | |
| 24.25 | |
| 24 | |
| 19-41.2 | |
| 1 244 M | |
| 50 101 K | |
| 1 046 M | |
| 0.52 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Lasa Supergenerics Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 046 M
- EBITDA -9 173 000
- Earnings Per Share -4.54
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Lasa Supergenerics Limited Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast NaN
Get Lasa Supergenerics Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
